CureVac’s Covid Vaccine Performed Badly in Trial, In Part Due to Variants
The results were a blow to hopes that the vaccine could help meet the world’s urgent need. “This is pretty devastating” for the company, one expert said.
from NYT > Health https://ift.tt/3iRcv0T
via health&fitness
Aucun commentaire:
Enregistrer un commentaire